Philip Quirke
Philip Quirke publishes mostly in Oncology, Surgery and Pathology and Forensic Medicine, on topics such as Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies and Genetic factors in colorectal cancer.
- World rank
- #50,517 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #4,091 of 367,258
- Works
- 870
- Citations
- 59k
- Citations per work
- 67.4
What does Philip Quirke research?
Philip Quirke's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences55563.8%
- Medicine55563.8%
- Everything else21424.6%
- Life Sciences10111.6%
- 1Oncology35% of their works
- 2Surgery14% of their works
- 3Pathology and Forensic Medicine8% of their works
- 4Molecular Biology7% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Cancer Research4% of their works
Research topics
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Colorectal Cancer Screening and Detection
- Colorectal and Anal Carcinomas
- Cancer Genomics and Diagnostics
- Gastric Cancer Management and Outcomes
- Radiomics and Machine Learning in Medical Imaging
Which keywords describe Philip Quirke's research?
The keywords of their largest research topics: Adjuvant Chemotherapy, Chemotherapy, Clinical Practice Guidelines, Preoperative Chemoradiotherapy, Rectal Cancer, Precision Medicine, Molecular Characterization and Cetuximab.
- Medical Imaging
- Endoscopic Resection
- Cancer Genomics
- Anal Cancer
- Colorectal Cancer
- Hereditary Syndromes
- Cetuximab
- Precision Medicine
- Preoperative Chemoradiotherapy
- Chemotherapy
- Adjuvant Chemotherapy
- Clinical Practice Guidelines
- Rectal Cancer
- Molecular Characterization
- KRAS Mutations
- Microsatellite Instability
- Screening
- Chemoradiation
- Mutational Signatures
- Gastric Cancer
- Radiomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Adjuvant Chemotherapy4052 topics
- Chemotherapy3603 topics
- Clinical Practice Guidelines3072 topics
- Preoperative Chemoradiotherapy2521 topic
- Rectal Cancer2521 topic
- Precision Medicine2422 topics
- Molecular Characterization2082 topics
- Cetuximab1911 topic
- KRAS Mutations1911 topic
- Hereditary Syndromes1531 topic
- Microsatellite Instability1531 topic
- Colorectal Cancer1451 topic
- Screening1451 topic
- Anal Cancer1141 topic
- Chemoradiation1141 topic
- Cancer Genomics731 topic
- Mutational Signatures731 topic
- Endoscopic Resection551 topic
- Gastric Cancer551 topic
- Medical Imaging511 topic
- Radiomics511 topic
Where does Philip Quirke work?
Philip Quirke's main affiliation in the publication record is University of Leeds, United Kingdom.
How many publications and citations does Philip Quirke have?
OpenAlex counts 870 works and 58,662 citations for Philip Quirke, an h-index of 114, ranking #50,517 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Philip Quirke. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.